Sec Form 13D Filing - PAULSON & CO. INC. filing for Bausch Health Companies Inc. (BHC) - 2020-05-15

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

SCHEDULE 13D

(RULE 13D - 101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)

(Amendment No. 2)*

BAUSCH HEALTH COMPANIES INC.
(Name of Issuer)

(Title of Class of Securities)

071734107
(CUSIP Number)

 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [  ].

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1)	See Note 1 to Item 5 below.

The following constitutes Amendment No. 2 to the Schedule 13D filed by the undersigned (“Amendment No. 2”). This Amendment No. 2 amends the Schedule 13D as specifically set forth herein.

Item 5 is hereby amended and restated to read as follows:

(a)            The aggregate percentage of Common Stock reported owned by the Reporting Person is based upon approximately 354,727,444 shares of Common Stock outstanding as of April 30, 2020, which is the total number of shares of Common Stock outstanding as disclosed on the  Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2020. As of the date hereof, the Reporting Person may be deemed to have beneficially owned approximately 7.28% of the outstanding Common Stock.

(b)            Number of shares of Common Stock as to which Paulson has:

(i) Sole power to vote or direct the vote: 25,839,035 (see Note 1).

(ii) Shared power to vote or direct the vote: 0

(iii) Sole power to dispose or direct the disposition: 25,839,035 (see Note 1).

(iv) Shared power to dispose or direct the disposition: 0

(c)            The transactions effected by the Reporting Person during the past 60 days are set forth on Schedule B attached hereto.

(d)            See Note 1.

(e)            Not applicable.

Note 1: The Reporting Person, an investment advisor that is registered under the Investment Advisers Act of 1940, furnishes investment advice to and manages the Funds. In its role as investment advisor, or manager, as the case may be, the Reporting Person possesses voting and investment power over the securities of the Issuer described in this Schedule 13D that are owned by the Funds. The pecuniary interest of all securities reported in this Schedule is owned by the Funds. Except for the purpose of determining beneficial ownership under Section 13(d) of the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of all securities reported in this Schedule 13D.

For reporting purposes, the aggregate amount of Common Stock deemed to be beneficially owned by the Reporting Person is calculated based on an aggregate 25,839,035 shares of Common Stock held by the Reporting Person as of the date hereof.

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated:  May 15, 2020

SCHEDULE B

Transactions of the Reporting Person Effected During the Past 60 Days

The following transactions were effected by Paulson & Co. Inc. on the open market during the past 60 days: